PharmStars

🔆 PharmStars Alumni Spotlight 🔆 RoseRx provides a compliant, conversational, hyperpersonalized patient and HCP agentic AI commercial platform. The pharmaceutical industry loses an estimated $35 billion in revenue annually because promotional content is not tailored to a patient’s treatment journey or the specific needs of the prescribing physician. Most of pharma's digital content is static, stale, generalized, and lacks real-time personalization. RoseRx’s medical, legal, and regulatory (MLR) trained AI agents continuously interface across pharma marketing channels, engaging patients and HCPs in compliant, personalized conversations that adapt based on real-time behaviors. Each agent is trained on a brand's approved content and provides dynamic, contextual, and compliant education to patients and HCPs.  Built from RoseRx’s proprietary data obtained by navigating 530,000 patients through digital prescription journeys across 22 conditions, their agents are now available for any therapeutic area. Clients have measured a 310% improvement in patient and HCP completion of recommended “Next Best Action” when compared with static content. Two top-ten global pharma companies are using their platform for conversational engagements in dermatology, cardiology, and urology. RoseRx is adding real-time support for field-sales teams and enhanced commercial analytics. 📸 #PharmStarsAlumni RoseRx CEO and Co-Founder Romain Bonjean responding to questions at the Spring 2026 PharmStars Startup Showcase. He participated in the program with colleagues Danielle Abbon and Sara Lim. PharmStars Ventures is proud to have RoseRx as a portfolio company. View all of PharmStars alumni companies on our website https://lnkd.in/gRPRGtP2

PharmStars’ pharma member Fireside Chats spotlight biopharma companies prioritizing digital innovation. We were pleased to welcome Jazz Pharmaceuticals’ Dr. Alison McReynolds, Customer Experience Transformation Workstream Lead, and Soo Son, Customer Experience Transformation KOL Workstream Lead, for a conversation with PharmStars’ CEO, Naomi Fried, Ph.D., and our current cohort of digital health startups. Jazz Pharmaceuticals has centralized its customer experience and related digital innovation work within a global Customer Experience Operations (CXO) group serving the U.S., Europe, and international markets. The group brings technology and development teams together to build tools for use across these regions. Its customer engagement and data analytics teams focus on personalizing interactions, identifying new patients, supporting medication adherence, and guiding conversations with HCPs. As a PharmStars pharma member, Jazz Pharmaceuticals engages with PharmStars’ digital health startups during the accelerator program, while they’re still learning how pharma works. These Fireside Chats help startups understand pharma priorities. In November, our pharma members will hear the startups pitch at the culminating Startup Showcase. These early connections lay the foundation for successful collaborations after graduation. Thanks again, Alison and Soo, for giving PharmStars’ Fall cohort a closer look at Jazz Pharmaceuticals’ approach to digital innovation. Jazz Pharmaceuticals is part of PharmStars’ growing community of biopharma companies taking a deliberate approach to digital innovation. If you’re a pharma innovation leader interested in joining this community, we’d be glad to connect.  Learn more about PharmStars membership: https://lnkd.in/gR--CGjn

September was full of exciting progress for our #PharmStarsAlumni! We're proud to highlight the latest accomplishments of digital health startups from the PharmStars accelerator as they continue to innovate and grow. Funding Rounds  ⭐ Cellular Vehicles was awarded a $2 million NIH Phase II SBIR grant to scale automated cell-laden hydrogel manufacturing on its Odyssey System Deals and Partnerships  ⭐ Infermedica announced a partnership with GP Triage to bring clinically certified AI triage to NHS general practice, supporting GP Triage's digital front door   ⭐ nference entered a long-term strategic collaboration with Rush University System for Health to develop a secure, Rush-hosted clinical analytics platform using de-identified longitudinal and multimodal clinical data  ⭐ Studypages partnered with Mars Veterinary Health to launch a dedicated clinical trial gallery that helps pet owners discover relevant veterinary studies, understand participation, and take steps toward enrollment Product Milestones  ⭐ acceXible launched a new conversational AI experience for its clinically validated cognitive assessment as part of its #WorldAlzheimersDay campaign in collaboration with Turn.io, Anthropic, and ElevenLabs  ⭐ Ailin.health obtained Categoría ALTA certification under Spain's National Security Framework (the highest level under RD 311/2022), adding to its existing ISO 27001 and ISO 27701 certifications  ⭐ Centaur.ai supported Median Technologies' eyonis® LCS FDA 510(k) clearance and Class IIb CE marking by assembling and managing 14 U.S. board-certified thoracic radiologists to produce the Reference Standard used in its standalone performance evaluation and MRMC study  ⭐ Elemeno Health is expanding across most Children's Wisconsin hospital units and clinic locations, building on use in its Cardiac Intensive Care Unit and an Acute Care Medical Specialty Unit Awards and Honors  ⭐ Elemeno Health has been recognized by the Inc. Magazine 5000 and the 2026 PurposeBuilt100™  ⭐ General Prognostics (GPx) was named a Rising Star Quarterfinalist in the Cardiometabolic, Obesity & Diabetes category of the 2026 The Digital Health Hub Foundation - Digital Health & AI Awards  ⭐ Head Diagnostics received two 2026 #RedDot Design Awards for iTremor, in “Product Design” and “Innovative Design in the Medical Devices and Technology” categories  ⭐ Local Infusion was named a “Best in Class” quarterfinalist in the “Therapeutics, Pharmacy & Medication Innovation” category of the 2026 The Digital Health Hub Foundation - Digital Health & AI Awards  ⭐ nference was named by TIME magazine among the World's Top HealthTech Companies  ⭐ Nivi, Inc. was selected as a finalist for the TiECON East Emerging Companies Showcase

Congratulations to Reflector Bio!! #PharmStarsAlumni 🎉

This semester’s PharmStars pharma member Fireside chats continued with Takeda! It was great having Kashif Jawaid, MD, Takeda’s Global Digital Health Product Portfolio Lead, and Stephanie Klock, Takeda’s Senior Director, Head of Patient Diagnosis Center of Excellence & Medical Analytics, join PharmStars’ CEO, Naomi Fried, Ph.D., to speak with our current cohort of digital health startups. This conversation offered a closer look at how Takeda organizes and prioritizes digital innovation across the pharma value chain. Its centralized team sits within the Data, Digital, and Technology organization, which reports to the Chief Data and Technology Officer. Digital experts within business units identify potential solutions and bring in the centralized team to support those initiatives. Thank you, Kashif and Stephanie, for giving PharmStars’ Fall cohort a closer look at Takeda’s approach to digital innovation. These conversations are one way PharmStars’ pharma members connect with our curated, vetted group of high-potential digital health startups. These startups have innovations ready for pharma to use today. Connections that begin at our virtual Fireside Chats continue into deeper engagement at the PharmStars Startup Showcase, an exclusive event for PharmStars’ pharma members. Takeda is part of PharmStars’ growing community of biopharma companies actively engaging with AI and digital health startups. If you’re a pharma innovation leader interested in joining this community of proactive, forward-thinking pharma companies, we’d be glad to connect. Learn more about PharmStars membership: https://lnkd.in/gR--CGjn

🔆 PharmStars Alumni Spotlight 🔆  WittGen Biotechnologies’ genAI platform provides single-cell precision simulation for molecular drug response prediction. Effective oncology drugs should attack only specific cancer cells while sparing healthy cells. But without knowing how each type of cell responds to a therapy, both efficacy and dangerous toxicity can go undetected. Only slow, expensive single-cell sequencing experiments can provide this information.  Wittgen’s generative AI platform rapidly and cost-effectively delivers cell-level detail by converting standard tissue-level sequencing data and pathology images into distinct cell-type profiles at the molecular level. Their platform generates multiomics-integrated “Virtual Cell” profiles (DNA, RNA, and protein information for each cell) that consistently simulate drug responses at the single-cell level, allowing pharma to access the benefits of traditional single-cell sequencing for 5% of the cost and 93% faster.  Using their platform, pharma can rapidly develop and evaluate more precise inclusion-exclusion criteria for Phase I and II trials without running additional experiments. Wittgen’s platform is clinically validated using 126 breast cancer patients from the National Cancer Institute Human Tumor Atlas Network.  Moffitt Cancer Center uses it to develop cell-specific biomarkers for colorectal cancer. Four biopharma clients have used the platform for target optimization and Phase II protocol design. By 2027, they plan to have digital twins that replicate every cell at the molecular level. 📸 #PharmStarsAlumni WittGen Biotechnologies CTO and Co-Founder Minwoo Jung presenting at the Spring 2026 PharmStars Startup Showcase. He participated in the program with Single-cell Lead Se-eun Han and CEO and Co-Founder Yun Rhie. PharmStars Ventures is proud to have WittGen Biotechnologies as a portfolio company. View all of PharmStars alumni companies on our website https://lnkd.in/gRPRGtP2

I'm grateful for the time and expertise that PharmStars’ Mentor Advisor, Dhiren Patel, PharmD, continues to share with our startups. 🙏 He recently gave our Fall 2026 cohort a masterclass on “Sales and Pricing Your Product for Pharma.” Dhiren discussed that startups seeking pharma clients must build relationships and earn trust across the organization for long-term success. Beyond advice and tips on this topic, Dhiren shared concrete, practical steps from his years selling to pharma. Dhiren also shared his wisdom with our startups at our Launch Event in September ( 📸 here he is speaking) and is actively mentoring one lucky startup this semester. I deeply appreciate his practical guidance, real-world perspective, and ongoing commitment to the PharmStars startups. Thank you, Dhiren!

One of the things I value most about PharmStars is the generosity of our Mentor Advisors. They bring years of pharma experience and a willingness to share their time and help our digital health startups understand how the industry works. Katherine Vandebelt is a wonderful example. After teaching our startups about drug development at our Launch Event, we were fortunate to welcome her back to #PharmaU for a session on pharma due diligence and contracting. In addition to one-on-one mentoring, Katherine’s teaching helps our startups understand pharma collaborations and how to prepare. Our startups often tell us how much her guidance helps them. I’m grateful they can learn directly from someone with such deep industry experience. Thank you, Katherine for the time, care, and expertise you share with our startups. We’re lucky to have you in the PharmStars' community!

PharmStars’ Fireside Chat series highlights how our biopharma member organizations approach digital health. Alexion Pharmaceuticals, Inc.’s Bhaskar Dutta, Head of Digital Health & Medical Affairs Technologies, recently joined PharmStars’ CEO, Naomi Fried, Ph.D., to speak with our current cohort of digital health startups. Alexion’s commitment to digital health predates its acquisition by AstraZeneca and remains a priority. Bhaskar emphasized that digital and AI are essential to Alexion’s ambitions to be the number one rare disease company.  Digital health innovation within Alexion follows a hybrid, hub-and-spoke model. The centralized hub is responsible for governance, policy, and standardization. Separate digital units within each function or therapeutic area address that business unit’s specific digital health innovation needs. Alexion is part of the PharmStars biopharma member community — a group of leaders who are all actively exploring and adopting AI and digital innovation. If you’re a pharma leader interested in engaging with high-potential, vetted startups, we’d be glad to connect. Learn more about PharmStars membership: https://lnkd.in/gR--CGjn